Sponsor
Profit margins, US medicine supplies may get hit: Biocon
Posted
Biocon anticipates potential challenges from proposed US tariffs on pharmaceutical imports, which could squeeze profit margins and affect the affordability of generic medicines. With the US being its largest market, Biocon is strategizing to navigate the impact, considering factors like tariff rates and competitor responses. The company is also focusing on expanding its presence in Europe to mitigate risks.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Isha shares heartfelt meaning of Raksha Bandhan
Isha Koppikar values Raksha Bandhan for its heartfelt presence and connection, not material...
Nepali festivals spread message of equality: Vice President Yadav
KATHMANDU: Vice President Ram Sahaya Prasad Yadav has expressed his confidence that the festivals...
Bazball's revolution: How England's bold era is tilting Test cricket towards the batters
Since Brendon McCullum's arrival, England's Test cricket has transformed with 'Bazball,' marked...
Faissal Khan feared dying of an 'overdose'
Faissal Khan, Aamir Khan's brother, alleges his family secretly medicated him, causing excessive...